hims glp-1 results Doctor Reacts: & Hers Weight Loss Review (Ad + Program) —What They Get Right & Wrong Hims & Hers data shows

CHARLEBOIS: GLP-1 drugs becoming Canadas $3.4 billion food disruption The food industry has always worried about inflation it should now worry about appetite Published May 02, 2026 Last updated May 02, 2026 3 minute read You can save this article by registering for free here

Health Canada confirmed it is reviewing eight other generic semaglutide submissions and expects further decisions in the coming weeks and months [Source: canada.ca/en/health-canada/news/2026/04/canada-becomes-the-first-g7-country-to-approve-a-generic-version-of-semaglutide.html]

The active ingredient in weight-loss drugs such as Wegovy and Zepbound is either semaglutide or tirzepatide, and both are on the list

These trials define both who can access treatment and what results they can expect